Hodsman, Anthony <br/><br/>
Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.  [electronic resource] 

 -  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne  Jul 2006 
 - 48 p.  digital 
<br/><br/> Publication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1488-2329 
<br/><br/><label>Standard No.: </label>10.1503/cmaj.060624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--adverse effects<br/>Canada<br/>Diphosphonates--adverse effects<br/>Drug Interactions<br/>Female<br/>Fractures, Bone--etiology<br/>Humans<br/>Osteoporosis--drug therapy<br/>Parathyroid Hormone--adverse effects<br/>Practice Guidelines as Topic<br/>Review Literature as Topic<br/>Teriparatide--adverse effects